Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MethylphenIdate for Fatigue in Haematological Cancer. A Randomized, Double-blind, Placebo-controlled, CROssover Trial - the MICRO Trial

NCT03218254 is registered in ClinicalTrials.gov with Henrik Frederiksen as lead sponsor.

NCT NCT03218254
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03218254 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MethylphenIdate for Fatigue in Haematological Cancer. A Randomized, Double-blind, Placebo-controlled, CROssover Trial - the MICRO Trial
Lead sponsor
Henrik Frederiksen
Phase
Phase 3
Overall status
Unknown status
Start date
June 8, 2018
Completion date
October 1, 2021
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematological cancer